Global Veterinary Biologics Market Research Report 2021

1 Veterinary Biologics Market Overview

• 1.1 Product Overview and Scope of Veterinary Biologics
• 1.2 Veterinary Biologics Segment by Type
  • 1.2.1 Global Veterinary Biologics Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Vaccines
  • 1.2.3 Monoclonal Antibodies
• 1.3 Veterinary Biologics Segment by Application
  • 1.3.1 Veterinary Biologics Sales Comparison by Application: (2021-2027)
  • 1.3.2 Llivestock
  • 1.3.3 Equine
  • 1.3.4 Other
• 1.4 Global Veterinary Biologics Market Size Estimates and Forecasts
  • 1.4.1 Global Veterinary Biologics Revenue 2016-2027
  • 1.4.2 Global Veterinary Biologics Sales 2016-2027
  • 1.4.3 Veterinary Biologics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Veterinary Biologics Market Competition by Manufacturers

• 2.1 Global Veterinary Biologics Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Veterinary Biologics Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Veterinary Biologics Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Veterinary Biologics Manufacturing Sites, Area Served, Product Type
• 2.5 Veterinary Biologics Market Competitive Situation and Trends
  • 2.5.1 Veterinary Biologics Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Veterinary Biologics Players Market Share by Revenue
  • 2.5.3 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Veterinary Biologics Retrospective Market Scenario by Region

• 3.1 Global Veterinary Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Veterinary Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Veterinary Biologics Market Facts & Figures by Country
  • 3.3.1 North America Veterinary Biologics Sales by Country
  • 3.3.2 North America Veterinary Biologics Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Veterinary Biologics Market Facts & Figures by Country
  • 3.4.1 Europe Veterinary Biologics Sales by Country
  • 3.4.2 Europe Veterinary Biologics Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Veterinary Biologics Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Veterinary Biologics Sales by Region
  • 3.5.2 Asia Pacific Veterinary Biologics Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Veterinary Biologics Market Facts & Figures by Country
  • 3.6.1 Latin America Veterinary Biologics Sales by Country
  • 3.6.2 Latin America Veterinary Biologics Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Veterinary Biologics Sales by Country
  • 3.7.2 Middle East and Africa Veterinary Biologics Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Veterinary Biologics Historic Market Analysis by Type

• 4.1 Global Veterinary Biologics Sales Market Share by Type (2016-2021)
• 4.2 Global Veterinary Biologics Revenue Market Share by Type (2016-2021)
• 4.3 Global Veterinary Biologics Price by Type (2016-2021)

5 Global Veterinary Biologics Historic Market Analysis by Application

• 5.1 Global Veterinary Biologics Sales Market Share by Application (2016-2021)
• 5.2 Global Veterinary Biologics Revenue Market Share by Application (2016-2021)
• 5.3 Global Veterinary Biologics Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Merck
  • 6.1.1 Merck Corporation Information
  • 6.1.2 Merck Description and Business Overview
  • 6.1.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Merck Product Portfolio
  • 6.1.5 Merck Recent Developments/Updates
• 6.2 Zoetis
  • 6.2.1 Zoetis Corporation Information
  • 6.2.2 Zoetis Description and Business Overview
  • 6.2.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Zoetis Product Portfolio
  • 6.2.5 Zoetis Recent Developments/Updates
• 6.3 Boehringer Ingelheim
  • 6.3.1 Boehringer Ingelheim Corporation Information
  • 6.3.2 Boehringer Ingelheim Description and Business Overview
  • 6.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Boehringer Ingelheim Product Portfolio
  • 6.3.5 Boehringer Ingelheim Recent Developments/Updates
• 6.4 Ceva
  • 6.4.1 Ceva Corporation Information
  • 6.4.2 Ceva Description and Business Overview
  • 6.4.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Ceva Product Portfolio
  • 6.4.5 Ceva Recent Developments/Updates
• 6.5 CAHIC
  • 6.5.1 CAHIC Corporation Information
  • 6.5.2 CAHIC Description and Business Overview
  • 6.5.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 CAHIC Product Portfolio
  • 6.5.5 CAHIC Recent Developments/Updates
• 6.6 HVRI
  • 6.6.1 HVRI Corporation Information
  • 6.6.2 HVRI Description and Business Overview
  • 6.6.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 HVRI Product Portfolio
  • 6.6.5 HVRI Recent Developments/Updates
• 6.7 Ringpu Biology
  • 6.6.1 Ringpu Biology Corporation Information
  • 6.6.2 Ringpu Biology Description and Business Overview
  • 6.6.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Ringpu Biology Product Portfolio
  • 6.7.5 Ringpu Biology Recent Developments/Updates
• 6.8 Yebio
  • 6.8.1 Yebio Corporation Information
  • 6.8.2 Yebio Description and Business Overview
  • 6.8.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Yebio Product Portfolio
  • 6.8.5 Yebio Recent Developments/Updates
• 6.9 DHN
  • 6.9.1 DHN Corporation Information
  • 6.9.2 DHN Description and Business Overview
  • 6.9.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 DHN Product Portfolio
  • 6.9.5 DHN Recent Developments/Updates
• 6.10 WINSUN
  • 6.10.1 WINSUN Corporation Information
  • 6.10.2 WINSUN Description and Business Overview
  • 6.10.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 WINSUN Product Portfolio
  • 6.10.5 WINSUN Recent Developments/Updates
• 6.11 Elanco/Eli Lilly
  • 6.11.1 Elanco/Eli Lilly Corporation Information
  • 6.11.2 Elanco/Eli Lilly Veterinary Biologics Description and Business Overview
  • 6.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Elanco/Eli Lilly Product Portfolio
  • 6.11.5 Elanco/Eli Lilly Recent Developments/Updates
• 6.12 Virbac
  • 6.12.1 Virbac Corporation Information
  • 6.12.2 Virbac Veterinary Biologics Description and Business Overview
  • 6.12.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Virbac Product Portfolio
  • 6.12.5 Virbac Recent Developments/Updates
• 6.13 Jinyu Bio-Technology
  • 6.13.1 Jinyu Bio-Technology Corporation Information
  • 6.13.2 Jinyu Bio-Technology Veterinary Biologics Description and Business Overview
  • 6.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Jinyu Bio-Technology Product Portfolio
  • 6.13.5 Jinyu Bio-Technology Recent Developments/Updates
• 6.14 ChengDu Tecbond
  • 6.14.1 ChengDu Tecbond Corporation Information
  • 6.14.2 ChengDu Tecbond Veterinary Biologics Description and Business Overview
  • 6.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 ChengDu Tecbond Product Portfolio
  • 6.14.5 ChengDu Tecbond Recent Developments/Updates
• 6.15 CAVAC
  • 6.15.1 CAVAC Corporation Information
  • 6.15.2 CAVAC Veterinary Biologics Description and Business Overview
  • 6.15.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 CAVAC Product Portfolio
  • 6.15.5 CAVAC Recent Developments/Updates
• 6.16 Kyoto Biken
  • 6.16.1 Kyoto Biken Corporation Information
  • 6.16.2 Kyoto Biken Veterinary Biologics Description and Business Overview
  • 6.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Kyoto Biken Product Portfolio
  • 6.16.5 Kyoto Biken Recent Developments/Updates
• 6.17 FATRO
  • 6.17.1 FATRO Corporation Information
  • 6.17.2 FATRO Veterinary Biologics Description and Business Overview
  • 6.17.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 FATRO Product Portfolio
  • 6.17.5 FATRO Recent Developments/Updates
• 6.18 Vaksindo
  • 6.18.1 Vaksindo Corporation Information
  • 6.18.2 Vaksindo Veterinary Biologics Description and Business Overview
  • 6.18.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Vaksindo Product Portfolio
  • 6.18.5 Vaksindo Recent Developments/Updates
• 6.19 Bio-Labs
  • 6.19.1 Bio-Labs Corporation Information
  • 6.19.2 Bio-Labs Veterinary Biologics Description and Business Overview
  • 6.19.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Bio-Labs Product Portfolio
  • 6.19.5 Bio-Labs Recent Developments/Updates
• 6.20 Avimex Animal
  • 6.20.1 Avimex Animal Corporation Information
  • 6.20.2 Avimex Animal Veterinary Biologics Description and Business Overview
  • 6.20.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Avimex Animal Product Portfolio
  • 6.20.5 Avimex Animal Recent Developments/Updates

7 Veterinary Biologics Manufacturing Cost Analysis

• 7.1 Veterinary Biologics Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Veterinary Biologics
• 7.4 Veterinary Biologics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Veterinary Biologics Distributors List
• 8.3 Veterinary Biologics Customers

9 Veterinary Biologics Market Dynamics

• 9.1 Veterinary Biologics Industry Trends
• 9.2 Veterinary Biologics Growth Drivers
• 9.3 Veterinary Biologics Market Challenges
• 9.4 Veterinary Biologics Market Restraints

10 Global Market Forecast

• 10.1 Veterinary Biologics Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Veterinary Biologics by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Veterinary Biologics by Type (2022-2027)
• 10.2 Veterinary Biologics Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Veterinary Biologics by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Veterinary Biologics by Application (2022-2027)
• 10.3 Veterinary Biologics Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Veterinary Biologics by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Veterinary Biologics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List